Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ECTRIMS 2024 | The concept of an MS prodomal phase and how it has long been neglected

Helen Tremlett • 9 Oct 2024
ECTRIMS 2024
Multiple Sclerosis and Related Disorders

Helen Tremlett, PhD, The University of British Columbia, Vancouver, Canada, discusses the concept of a prodromal phase in multiple sclerosis (MS) and how it has been neglected. She speaks about how research into a prodromal phase in Parkinson’s has led to therapeutic advancements in early disease stages. This interview took place at the 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2024) in Copenhagen, Denmark.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Helen Tremlett

Lower cognitive performance before MS symptom onset: a Norweigan study
1:57
Lower cognitive performance before MS symptom onset: a Norweigan study
Helen Tremlett • 9 Oct 2024
The clinical significance of a prodromal phase in MS
3:35
The clinical significance of a prodromal phase in MS
Helen Tremlett • 9 Oct 2024
Increased healthcare use before MS onset as evidence for a potential prodromal phase
3:04
Increased healthcare use before MS onset as evidence for a potential prodromal phase
Helen Tremlett • 9 Oct 2024
Comparing the prodromal phase in MS to other immune-mediated diseases
2:42
Comparing the prodromal phase in MS to other immune-mediated diseases
Helen Tremlett • 9 Oct 2024

Related Videos

Phase II open-label extension of frexalimab in participants with relapsing multiple sclerosis
6:10
Phase II open-label extension of frexalimab in participants with relapsing multiple sclerosis
Patrick Vermersch • 24 Apr 2026
A digital tool to detect disability worsening in multiple sclerosis: the MS-DETECT study
4:36
A digital tool to detect disability worsening in multiple sclerosis: the MS-DETECT study
Patrick Vermersch • 24 Apr 2026
Red flags for genetic demyelinating conditions and risks of misdiagnosing as MS
3:05
Red flags for genetic demyelinating conditions and risks of misdiagnosing as MS
Holly Appleberry • 19 Apr 2026
Advancing research and care in adult-onset genetic leukoencephalopathies
2:01
Advancing research and care in adult-onset genetic leukoencephalopathies
Holly Appleberry • 19 Apr 2026
The content of VJNeurology is intended for healthcare professionals